IXICO plc (LON:IXI – Get Free Report) rose 16.9% during trading on Tuesday. The company traded as high as GBX 12.50 and last traded at GBX 11.98. Approximately 449,418 shares changed hands during trading, an increase of 314% from the average daily volume of 108,557 shares. The stock had previously closed at GBX 10.25.
IXICO Price Performance
The stock has a market capitalization of £26.28 million, a PE ratio of -6.15, a P/E/G ratio of -0.38 and a beta of 0.11. The company has a debt-to-equity ratio of 5.22, a current ratio of 2.83 and a quick ratio of 4.90. The firm’s 50 day simple moving average is GBX 8.05 and its 200 day simple moving average is GBX 8.28.
About IXICO
IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.
By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.
See Also
- Five stocks we like better than IXICO
- Why Meta Platform’s $100 Billion Financing Plan Is A Boon for Chip Giant Broadcom
- Enphase Energy’s Solar Slump Raises a Question About Its AI Data Center Ambitions
- 1 Frozen Housing Market, 2 Very Different Earnings Stories
- 3 Energy Stocks Boosting Dividends as the Sector Widens Its 2026 Performance Lead
Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.
